Next Med

Next Med operates as a telehealth-focused peptide therapy practice serving patients throughout New York, with providers licensed to prescribe evidence-based peptide protocols for metabolic health, immune support, and age-related decline. The clinic structures treatment around comprehensive lab analysis, using biomarkers to guide peptide selection rather than applying standardized protocols. Patients access consultations remotely, receive prescriptions through partner pharmacies, and follow structured monitoring schedules that track response metrics over 8-12 week cycles.

Next Med offers a range of peptide therapy options tailored to individual patient needs. Treatment protocols are customized based on health goals, lab work, and medical history, with options for hormone optimization, metabolic health, tissue repair, and performance enhancement.

Providers at Next Med hold credentials in functional medicine, endocrinology, or integrative health, with training in peptide pharmacology and hormone optimization. The clinical approach prioritizes root cause analysis over symptom suppression, using peptides as targeted interventions within broader metabolic or immune dysfunction patterns. Initial consultations involve detailed health histories, review of previous lab work, and discussion of treatment goals tied to measurable outcomes such as HbA1c reduction, inflammatory marker changes, or body composition shifts. Providers explain peptide mechanisms, expected timelines for response, and potential side effects specific to each compound.

Patients beginning treatment with Next Med complete baseline laboratory panels that typically include metabolic markers, hormone levels, inflammatory cytokines, and thyroid function depending on clinical presentation. After peptide initiation, the clinic schedules follow-up consultations at 4-6 week intervals to assess subjective response and review repeat labs where indicated. Peptide administration occurs via subcutaneous injection, with patients receiving detailed instruction on reconstitution, dosing, and injection technique during onboarding. The clinic provides access to compounded peptides through FDA-registered 503B facilities, ensuring pharmaceutical-grade quality and sterility testing.

Next Med's telehealth model eliminates geographic barriers for New York residents seeking peptide therapy outside traditional endocrinology or anti-aging clinic settings. Consultations occur via HIPAA-compliant video platform, with secure messaging available for questions between appointments. The practice does not accept insurance but provides itemized superbills for patients to submit for potential reimbursement. Treatment costs vary based on peptide selection and dosing frequency, with transparency provided during initial consultation regarding monthly medication expenses and monitoring requirements. The clinic maintains relationships with multiple compounding pharmacies to ensure peptide availability and competitive pricing for patients committed to multi-month protocols.